# Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

> **NCT06671821** · PHASE2 · COMPLETED · sponsor: **Shandong Suncadia Medicine Co., Ltd.** · enrollment: 81 (actual)

## Conditions studied

- Chronic Weight Management

## Interventions

- **DRUG:** HRS-7535

## Key facts

- **NCT ID:** NCT06671821
- **Lead sponsor:** Shandong Suncadia Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-20
- **Primary completion:** 2025-08-15
- **Final completion:** 2025-09-28
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2025-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671821, "Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT06671821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*